Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC) Trial

NCT03879629 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03879629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03879629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC) Trial
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
August 21, 2019
Completion date
February 28, 2026
Enrollment
224 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer